Author

Fabrizio Ganzina

Observed names: F Ganzina, F. GANZINA, F. Ganzina, Franco Ganzina

Observed institutions: Nagasaki University, Instituto Nazionale Tumori Regina Elena, University of Genoa

OpenAlex ID: A5111707282

4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data

1983 · Fabrizio Ganzina · Cancer Treatment Reviews · 179

A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia

1991 · Franco Mandelli, Maria C. Petti, et al. · European Journal of Cancer and Clinical Oncology · 98

Idarubicin (4-demethoxydaunorubicin)

1986 · F. Ganzina, M. A. Pacciarini, et al. · Investigational New Drugs · 73

Idarubicin in the treatment of acute leukemias. An overview of preclinical and clinical studies.

1990 · A M Carella, E Berman, et al. · PubMed · 54

High-Dose Medroxyprogesterone Acetate (MPA) Treatment in Advanced Breast Cancer. A Review

1979 · Fabrizio Ganzina · Tumori Journal · 49

Clinical Toxicity of 4′-Epi-Doxorubicin (Epirubicin)

1985 · Fabrizio Ganzina, Nicola Di Pietro, et al. · Tumori Journal · 40

Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncology

1982 · V. Tamassia, A. Battaglia, et al. · Cancer Chemotherapy and Pharmacology · 33

Phase II trial with oral idarubicin in advanced breast cancer

1986 · Massimo Lopez, Luigi Di Lauro, et al. · Investigational New Drugs · 26

Caerulein (ceruletide). A review.

1976 · F Ganzina, A Santamaria · PubMed · 19

Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemia

1987 · Giorgio Lambertenghi-Deliliers, Anna Teresa Maiolo, et al. · European Journal of Cancer and Clinical Oncology · 18

Clinical evaluation of 4′-epi-doxorubicin in advanced solid tumors

1983 · Gioacchino Robustelli Della Cuna, Lorenzo Pavesi, et al. · Investigational New Drugs · 18

Clinical studies with new anthracyclines: epirubicin, idarubicin, esorubicin.

1986 · P Hurteloup, F Ganzina · PubMed · 17

Phase II Study of 4'Epi-Doxorubicin

1982 · Eros Ferrazzi, Ornella Nicoletto, et al. · Tumori Journal · 15

Combination chemotherapy with oral idarubicin and cyclophosphamide for metastatic breast cancer

1991 · Massimo Lopez, Patrizia Vici, et al. · Journal of Cancer Research and Clinical Oncology · 13

Idarubicin in combination with etoposide and cytarabine in adult untreated acute non lymphoblastic leukemia

1987 · Angelo M. Carella, Marina Martinengo, et al. · European Journal of Cancer and Clinical Oncology · 13

Phase II study of epirubicin in advanced malignant melanoma

1984 · Massimo Lopez, Carlo-Federico Perno, et al. · Investigational New Drugs · 13

Controlled study of DTIC versus DTIC plus epirubicin in metastatic malignant melanoma

1984 · Massimo Lopez, Carlo-Federico Perno, et al. · Investigational New Drugs · 13

Idarubicin combined with intermediate-dose cytosine arabinoside in the treatment of refractory acute leukemia.

1989 · G Leone, L Pagano, et al. · PubMed · 10

Epirubicin in non-Hodgkinʼs lymphomas

1985 · Massimo Lopez, Luigi Di Lauro, et al. · American Journal of Clinical Oncology · 10

Phase II Trial of Oral Idarubicin in Advanced Non-Small Cell Lung Cancer (NSCLC)

1988 · Andrea Ardizzoni, Paolo Pronzato, et al. · Cancer Investigation · 8

Epirubicin in Combination Chemotherapy in the Treatment of Advanced Stage Non-Hodgkin's Lymphomas

1987 · Giuseppe Abate, Pasquale Cornelia, et al. · Tumori Journal · 6

Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma.

1986 · M Lopez, L Di Lauro, et al. · PubMed · 6

A phase II study of 4′-epi-doxorubicin plus cis-platinum in advanced solid tumors

1984 · Andrea Martoni, Luciana Tomasi, et al. · European Journal of Cancer and Clinical Oncology · 4

Chemotherapy and hormonal treatment of advanced breast cancer

1982 · G. Robustelli della Cuna, A. Pelligrini, et al. · 1

73 P - Oral idarubicin (OIDA) in elderly patients (pts) with acute myelogenous Leukemia (AML): An opportunity?

1996 · F.C.A. Visentin, F. Ganzina, et al. · European Journal of Cancer

Works count: 31

Citation count: 736

H-index: 13

I10-index: 19